BRIEF published on 11/26/2025 at 15:25, 9 months 21 days ago The Vanguard Group Discloses Position in Qualcomm Inc. Securities Disclosure Takeover Code Vanguard Qualcomm
BRIEF published on 11/26/2025 at 15:24, 9 months 21 days ago The Vanguard Group Discloses Stake in American Axle & Manufacturing Form 8.3 Takeover Code Vanguard Group Shareholding American Axle
BRIEF published on 11/26/2025 at 15:22, 9 months 21 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Vanguard Group Financial Disclosure Shareholding Takeover Panel Avadel Pharmaceuticals
BRIEF published on 11/26/2025 at 15:21, 9 months 21 days ago The Vanguard Group Discloses Stake in Mural Oncology plc Vanguard Group Stake Disclosure Investment Transparency Irish Takeover Rules Mural Oncology
PRESS RELEASE published on 11/26/2025 at 15:20, 9 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group discloses a 10.79% stake in Qualcomm Incorporated as of 25 Nov 2025 according to Form 8.3 Form 8.3 Vanguard Group Stake Disclosure Financial Holdings Qualcomm Incorporated
BRIEF published on 11/26/2025 at 15:20, 9 months 21 days ago The Vanguard Group's Stake in Greencore Group plc Disclosed Vanguard Group Share Disclosure Financial Investment UK Takeover Code Greencore Group
PRESS RELEASE published on 11/26/2025 at 15:19, 9 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.50% interest in American Axle & Manufacturing Holdings, Inc. with 8,896,665 securities held. Purchase of 24,373 USD 0.01 common securities at 6.37 USD per unit Securities Disclosure Vanguard Group Purchase American Axle
PRESS RELEASE published on 11/26/2025 at 15:17, 9 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses owning 5.73% of Avadel Pharmaceuticals plc's US$0.01 ordinary shares. Purchase of 4,554 shares at 22.93 USD per share on 25 November 2025 The Vanguard Group Inc. Stock Purchase Ownership Disclosure Financial Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE published on 11/26/2025 at 15:16, 9 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.41% interest in Mural Oncology plc's securities through Form 8.3 with dealings on 25 November 2025 Securities Form 8.3 The Vanguard Group Dealings Mural Oncology Plc
PRESS RELEASE published on 11/26/2025 at 15:15, 9 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.34% stake in Greencore Group plc. Open position disclosure under Rule 8.3 of the Takeover Code Position Disclosure The Vanguard Group Rule 8.3 Takeover Code Greencore Group Plc
Published on 09/18/2026 at 00:55, 4 hours 48 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 5 hours 18 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 7 hours 28 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 7 hours 28 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/18/2026 at 05:30, 13 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/17/2026 at 19:00, 10 hours 43 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 10 hours 45 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 11 hours 18 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 11 hours 33 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:40, 12 hours 3 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 11 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 22 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
